NUREXONE BIOLOGIC INC (NRX.CA) Stock Overview
TSX-V:NRX - CA67059R1091 - Common Stock
NRX.CA Key Statistics, Chart & Performance
The current stock price of NRX.CA is 0.83 CAD. In the past month the price increased by 16.9%. In the past year, price increased by 43.1%.
NRX.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EDT.CA | SPECTRAL MEDICAL INC | N/A | 425.87M | ||
| FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 343.98M | ||
| EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 266.82M | ||
| TH.CA | THERATECHNOLOGIES INC | N/A | 204.61M | ||
| HBP.CA | HELIX BIOPHARMA CORP | N/A | 103.88M | ||
| WLLW.CA | WILLOW BIOSCIENCES INC | N/A | 97.56M | ||
| MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 90.92M | ||
| BLU.CA | BLUENERGIES LTD | N/A | 82.42M | ||
| COV.CA | COVALON TECHNOLOGIES LTD | 18.46 | 65.81M | ||
| MSCL.CA | SATELLOS BIOSCIENCE INC | N/A | 60.21M | ||
| SVA.CA | SERNOVA BIOTHERAPEUTICS INC | N/A | 45.90M | ||
| MBX.CA | MICROBIX BIOSYSTEMS INC | N/A | 32.91M |
Related stock screener links
About NRX.CA
Company Profile
NurExone Biologic, Inc. is a pharmaceutical company, which engages in the development and commercialization of biological extracellular vesicles-based technology drug platforms. The firm is engaged in developing a platform for biologically guided exosome-based therapies to be delivered, minimally invasive, to patients who have suffered central nervous system injuries. The Company’s first product, ExoPTEN for acute spinal cord injury, uses exosomes loaded with a specific and proprietary sIRNA sequence as the active pharmaceutical ingredient. Its ExoTherapy is a proprietary platform for developing exosome-based therapies. The NurExone platform technology is expected to offer solutions to drug companies interested in minimally invasive targeted drug delivery for other indications.
Company Info
NUREXONE BIOLOGIC INC
Minus 1 Entry, Ground Floor Of Bldg B
Haifa ALBERTA IL
Employees: 12
Phone: 972524803034
NUREXONE BIOLOGIC INC / NRX.CA FAQ
What is the stock price of NUREXONE BIOLOGIC INC today?
The current stock price of NRX.CA is 0.83 CAD. The price increased by 1.22% in the last trading session.
What is the ticker symbol for NUREXONE BIOLOGIC INC stock?
The exchange symbol of NUREXONE BIOLOGIC INC is NRX and it is listed on the TSX Venture Exchange exchange.
On which exchange is NRX.CA stock listed?
NRX.CA stock is listed on the TSX Venture Exchange exchange.
What is the price forecast or stock price prediction for NUREXONE BIOLOGIC INC stock?
9 analysts have analysed NRX.CA and the average price target is 3.12 CAD. This implies a price increase of 275.43% is expected in the next year compared to the current price of 0.83. Check the NUREXONE BIOLOGIC INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is NUREXONE BIOLOGIC INC worth?
NUREXONE BIOLOGIC INC (NRX.CA) has a market capitalization of 66.41M CAD. This makes NRX.CA a Micro Cap stock.
How many employees does NUREXONE BIOLOGIC INC have?
NUREXONE BIOLOGIC INC (NRX.CA) currently has 12 employees.
What are the support and resistance levels for NUREXONE BIOLOGIC INC (NRX.CA) stock?
NUREXONE BIOLOGIC INC (NRX.CA) has a support level at 0.82 and a resistance level at 0.84. Check the full technical report for a detailed analysis of NRX.CA support and resistance levels.
Should I buy NUREXONE BIOLOGIC INC (NRX.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NRX.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NRX.CA, evaluating the profitability, health, valuation and growth aspects
- NUREXONE BIOLOGIC INC (NRX.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- NUREXONE BIOLOGIC INC (NRX.CA) Sales and EPS estimates to see what analysts future expectations are.
- NUREXONE BIOLOGIC INC (NRX.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- NUREXONE BIOLOGIC INC (NRX.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- NUREXONE BIOLOGIC INC (NRX.CA) Stock Chart to make your own analysis
- NUREXONE BIOLOGIC INC (NRX.CA) Latest news and press-releases to stay up to date.
Does NUREXONE BIOLOGIC INC (NRX.CA) stock pay dividends?
NRX.CA does not pay a dividend.
What is the Price/Earnings (PE) ratio of NUREXONE BIOLOGIC INC (NRX.CA)?
NUREXONE BIOLOGIC INC (NRX.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.12).
NRX.CA Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to NRX.CA. When comparing the yearly performance of all stocks, NRX.CA is one of the better performing stocks in the market, outperforming 79.7% of all stocks.
NRX.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to NRX.CA. While NRX.CA seems to be doing ok healthwise, there are quite some concerns on its profitability.
NRX.CA Financial Highlights
Over the last trailing twelve months NRX.CA reported a non-GAAP Earnings per Share(EPS) of -0.12. The EPS decreased by -4% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -270.98% | ||
| ROE | -440.65% | ||
| Debt/Equity | 0.02 |
NRX.CA Forecast & Estimates
9 analysts have analysed NRX.CA and the average price target is 3.12 CAD. This implies a price increase of 275.43% is expected in the next year compared to the current price of 0.83.